Back Login for AI Analysis

    IMVT (STOCKS)

    Immunovant, Inc. Common Stock

    $41.716100
    -0.883900 (-2.07%)
    Prev close: $42.600000
    Company Information
    Exchange
    XNAS
    Sector
    Health Technology
    Industry
    Biotechnology
    CEO
    Eric Venker
    Asset Type
    stocks
    Website
    Visit
    Fundamentals
    Market Cap
    $9,555.45M
    Employees
    362
    P/E (TTM)
    -14.89
    P/B (TTM)
    11.95
    Dividend Yield
    Technical Indicators
    SMA 10
    SMA 20
    SMA 50
    EMA 9
    EMA 21
    RSI
    MACD State

    Analyst Recommendations
    9
    Strong Buy
    9
    Buy
    4
    Hold
    0
    Sell
    Recent News

    No recent news found for this ticker.

    Earnings Surprises
    Period Actual Estimate Surprise Surprise %
    Jun 2026 (Q1)
    $-0.75 $-0.63 -0.1223 -19.48%
    Mar 2026 (Q4)
    $-0.73 $-0.61 -0.1171 -19.11%
    Dec 2025 (Q3)
    $-0.61 $-0.73 +0.1185 +16.27%
    Sep 2025 (Q2)
    $-0.73 $-0.73 +0.0015 +0.21%